Clinical Trial

Conservative Management of Left Ventricular Assist Device Candidates

Recruiting
View on ClinicalTrials.gov →
Summary
Left ventricular assist device (LVAD) candidates will be comprehensively evaluated at our center, including clinical evaluation, echocardiography, right heart catheterization, cardiopulmonary exercise test and laboratory exams. following this evaluation, patients will be treated with inotropes, diuretics, uptitrated neurohormonal therapy. vitamin and iron deficiencies will be corrected and the patients will be referred for coronary interventions and cardiac resynchronization therapy appropriately. The need for LVAD implantation will be reevaluated according to the patient's clinical condition, echocardiography and laboratory findings.
Trial Details
NCT Number NCT05271214
Lead Sponsor Tel-Aviv Sourasky Medical Center
Conditions Advanced Heart Failure
Enrollment 100 participants
Start Date 2018-01-01
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2022-03-08